These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 921875)

  • 1. Calcium and magnesium contents of malignant hyperpyrexia-susceptible human muscle.
    Bennett D; Cain PA; Ellis FR; Louis CF; Stanton M
    Br J Anaesth; 1977 Oct; 49(10):979-82. PubMed ID: 921875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical basis of malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):241-4. PubMed ID: 4827070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs.
    Nelson TE; Chausmer AB
    J Pharmacol Exp Ther; 1981 Oct; 219(1):107-11. PubMed ID: 7288598
    [No Abstract]   [Full Text] [Related]  

  • 4. Total calcium content of skeletal muscle isolated from humans and pigs susceptible to malignant hyperthermia.
    Britt BA; Endrenyi L; Barclay RL; Cadman DL
    Br J Anaesth; 1975 Jun; 47(6):647-53. PubMed ID: 1148084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of halothane on the rate of acid production, lactate production and pyruvate dehydrogenase activity of malignant hyperpyrexia human muscle.
    Bennett D; Cain P; Ellis FR; Halsall J; Louis CF
    Br J Anaesth; 1978 Aug; 50(8):799-803. PubMed ID: 678367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Malignant hyperpyrexia.
    Moulds RF
    Lancet; 1975 Mar; 1(7908):681. PubMed ID: 47102
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of susceptibility to malignant hyperpyrexia.
    Moulds RF; Denborough MA
    Br Med J; 1974 May; 2(5913):245-7. PubMed ID: 4827071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.
    O'Brien PJ
    Can J Vet Res; 1986 Jul; 50(3):318-28. PubMed ID: 3742367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment of malignant hyperpyrexia.
    Austin KL; Denborough MA
    Anaesth Intensive Care; 1977 Aug; 5(3):207-13. PubMed ID: 900461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium uptake into muscle of pigs susceptible to malignant hyperthermia: in vitro and in vivo studies with and without halothane.
    Britt BA; Endrenyi L; Cadman DL
    Br J Anaesth; 1975 Jun; 47(6):650-3. PubMed ID: 238550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperpyrexia.
    Foster PS
    Int J Biochem; 1990; 22(11):1217-22. PubMed ID: 2175272
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium and magnesium content of skeletal muscle. Studies in subjects undergoing diagnostic testing for malignant hyperthermia.
    Nelson TE; Flewellen EH; Belt MW; Kennamer DL; Winsett OE; Bee DE
    Br J Anaesth; 1987 Jun; 59(6):730-4. PubMed ID: 3606917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ inactivation, Mg2+ inhibition and malignant hyperthermia.
    Lamb GD
    J Muscle Res Cell Motil; 1993 Dec; 14(6):554-6. PubMed ID: 8126214
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium uptake by isolated sarcoplasmic reticulum: examination of halothane inhibition, pH dependence, and Ca2+ dependence of normal and malignant hyperthermic human muscle.
    Blanck TJ; Gruener R; Suffecool SL; Thompson M
    Anesth Analg; 1981 Jul; 60(7):492-8. PubMed ID: 7195664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
    López JR; Alamo LA; Jones D; Papp L; Allen P; Gergely J; Streter F
    Acta Cient Venez; 1985; 36(1):102-4. PubMed ID: 4090898
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.
    Isaacs H; Heffron JJ
    Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of malignant hyperpyrexia.
    Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin secretion in malignant hyperpyrexia.
    Denborough MA; Warne GL; Moulds RF; Martin FI
    Br Med J; 1974 Aug; 3(5929):493-5. PubMed ID: 4413915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
    Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle.
    Glover L; Heffron JJ; Ohlendieck K
    J Appl Physiol (1985); 2004 Jan; 96(1):11-8. PubMed ID: 12959958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.